All Companies
INVA
Innoviva, Inc. Common StockPharmaceutical Preparations
$21.14updated Sep 19, 2026
Congressional trading profile for Innoviva, Inc. Common Stock (INVA), covering 2 disclosed transactions by 1 lawmakers.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Total Trades
2
Politicians Trading
1
Last Traded
Mar 25, 2025
Price history